2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

François Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G. De Backer, Victoria Delgado, Brian A. Ference, Ian M. Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J. Richter, Marc S. Sabatine, Marja Riitta Taskinen, Lale TokgozogluOlov Wiklund, Christian Mueller, Heinz Drexel, Victor Aboyans, Alberto Corsini, Wolfram Doehner, Michel Farnier, Bruna Gigante, Meral Kayikcioglu, Goran Krstacic, Ekaterini Lambrinou, Basil S. Lewis, Josep Masip, Philippe Moulin, Steffen Petersen, Anna Sonia Petronio, Massimo Francesco Piepoli, Xavier Pinto, Lorenz Raber, Kausik K. Ray, Zeljko Reiner, Walter F. Riesen, Marco Roffi, Jean Paul Schmid, Evgeny Shlyakhto, Iain A. Simpson, Erik Stroes, Isabella Sudano, Alexandros D. Tselepis, Donna Fitzsimons

Research output: Contribution to journalReview articlepeer-review

6707 Citations (Scopus)
Original languageEnglish
Pages (from-to)111-188
Number of pages78
JournalEuropean Heart Journal
Volume41
Issue number1
DOIs
Publication statusPublished - 31 Aug 2019

Keywords

  • Apolipoprotein B
  • Cholesterol
  • Dyslipidaemias
  • Familial hypercholesterolaemia
  • Guidelines
  • High-density lipoproteins
  • Lipoprotein remnants
  • Lipoprotein(a)
  • Low-density lipoproteins
  • Total cardiovascular risk
  • Treatment (adherence)
  • Treatment (drugs)
  • Treatment (lifestyle)
  • Triglycerides
  • Very low-density lipoproteins

Cite this